Patents matching “treatment”

US 6562942

Methods for treatment of diabetes using peptide analogues of insulin

Neurocrine Biosciences, Inc. · Granted May 13, 2003 · Expires May 8, 2023

RU 2203884

RETINOID COMPOUNDS (VARIANTS), COMPOSITION, METHOD FOR ASSAY OF RETINOID HORMONE ANTAGONISTS, METHOD OF TREATMENT AND INTERMEDIATE SUBSTANCES

ALLERGEN SEJLZ INK [US] · Granted May 10, 2003 · Expires May 5, 2023

US 6558668

Methods for detection and treatment of neural cancers

The Regents of the University of California · Granted May 6, 2003 · Expires May 1, 2023

US 6555585

Use of derivatives of valproic acid and 2-valproenic acid amides for the treatment of mania in bipolar disorder

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Apr 29, 2003 · Expires Apr 24, 2023

US 6555582

Eye treatments using synthetic thyroid hormone compositions

The Regents of the University of California · Granted Apr 29, 2003 · Expires Apr 24, 2023

US 6552006

Immunomodulatory polynucleotides in treatment of an infection by an intracellular pathogen

The United States of America as represented by the Department of Veteran Affairs · Granted Apr 22, 2003 · Expires Apr 17, 2023

US 6545034

Use of etodolac for the treatment of chronic lymphocytic leukemia

The Regents of the University of California · Granted Apr 8, 2003 · Expires Apr 3, 2023

US 6537768

Diagnosis, prevention and treatment of ulcerative colitis, and clinical subtypes thereof, using microbial UC panca antigens

The Regents of the University of California · Granted Mar 25, 2003 · Expires Mar 20, 2023

US 6534283

Method for treatment and prevention of physiological shock

The Regents of the University of California · Granted Mar 18, 2003 · Expires Mar 13, 2023

US 6531506

Inhibitors of epoxide hydrolases for the treatment of hypertension

The Regents of the University of California · Granted Mar 11, 2003 · Expires Mar 6, 2023

US 6525096

GABA and L-glutamic acid analogs for antiseizure treatment

Northwestern University · Granted Feb 25, 2003 · Expires Feb 20, 2023

US 6515003

Heterocyclic derivatives for the treatment of diabetes and other diseases

Maxim Pharmaceuticals, Inc. · Granted Feb 4, 2003 · Expires Jan 30, 2023

US 6511988

Activated iododerivatives for the treatment of cancer and aids

Isotechnika, Inc. · Granted Jan 28, 2003 · Expires Jan 23, 2023

US 6509319

EDTA and other chelators with or without antifungal antimicrobial agents for the prevention and treatment of fungal infections

The Board of Regents of the University of Texas System · Granted Jan 21, 2003 · Expires Jan 16, 2023

US 6509492

Tannate compositions and methods of treatment

First Horizon Pharmaceutical Corporation · Granted Jan 21, 2003 · Expires Jan 16, 2023

US 6503915

Composition and method for treatment of cerebral ischemia

The Board of Regents of the University of Texas System · Granted Jan 7, 2003 · Expires Jan 2, 2023

US 6503916

Treatment of ischemic brain injury

The Board of Regents of the University of Texas System · Granted Jan 7, 2003 · Expires Jan 2, 2023

US 6500834

Composition and method for treatment of cerebral ischemia

The Board of Regents of the University of Texas System · Granted Dec 31, 2002 · Expires Dec 26, 2022

US 6492426

Use of 1-aminoindan derivatives for treatment of mania in bipolar mood disorder

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Dec 10, 2002 · Expires Dec 5, 2022

US 6489299

Methods for treatment of multiple sclerosis using peptide analogues at position 91 of human myelin basic protein

Neurocrine Biosciences, Inc. · Granted Dec 3, 2002 · Expires Nov 28, 2022

US 6489308

Inhibitors of serine protease activity, methods and compositions for treatment of nitric-oxide-induced clinical conditions

The Regents of the University of Technology Office of Technology Transfer · Granted Dec 3, 2002 · Expires Nov 28, 2022

US 6486166

Suppression of cyclin kinase 2 activity for prevention and treatment of DNA viral infections

The Board of Regents of the University of Texas · Granted Nov 26, 2002 · Expires Nov 21, 2022

US 6475724

Nucleic acids, kits, and methods for the diagnosis, prognosis and treatment of glaucoma and related disorders

The Regents of the University of California · Granted Nov 5, 2002 · Expires Oct 31, 2022

US 6470220

Diagnosis and treatment of cancers using in vivo magnetic domains

The Regents of the University of California · Granted Oct 22, 2002 · Expires Oct 17, 2022